Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea.
Research context
Aprogen pharmaceuticals,Inc appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Aprogen pharmaceuticals,Inc is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 19.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Aprogen pharmaceuticals,Inc's total revenue sank by 14.7% to $13B since the same quarter in the previous year.
Its net income has increased by 70.9% to $-850M since the same quarter in the previous year.
Finally, its free cash flow grew by 2211.5% to $4B since the same quarter in the previous year.
Based on the above factors, Aprogen pharmaceuticals,Inc gets an overall score of 3/5.